In response to the major strategic needs of the development of my country's biomedical materials industry, this project takes innovation as the core, explores a new mode of integrated development of the whole industry chain integrating production, learning, research, medicine, inspection, and finance (finance), and builds the "South China Biomedical" "Material and Implantable Device Innovation Demonstration Base", develops a variety of new tissue repair materials for some typical clinical difficult problems and needs, conducts basic research, engineering, performance and quality evaluation, clinical trials, etc. The industrialization of tissue repair materials and cardiovascular interventional/implantable devices provides an important demonstration for my country to achieve leapfrog development of the biomaterial industry through independent innovation and lead the development of related international fields. The setting of the subject is based on the characteristics of the whole industry chain of biomaterials and the division of labor according to the tasks of building four major platforms, namely, building an innovative technology platform for functional design and manufacturing of new biomedical materials, an engineering platform, a testing and evaluation platform, and a clinical transformation and promotion platform. , each subject is closely linked through the specific clinical problems and target materials targeted, and social funds are guided by government funds to participate in the form of industrial investment funds to achieve basic research, technological innovation, scientific research transformation, testing services, clinical applications, and enterprises. Incubation and other integrated development.
